393 related articles for article (PubMed ID: 34132354)
1. A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review).
Falzone L; Scandurra G; Lombardo V; Gattuso G; Lavoro A; Distefano AB; Scibilia G; Scollo P
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34132354
[TBL] [Abstract][Full Text] [Related]
2. Borderline ovarian tumors" A contemporary review of clinicopathological characteristics, diagnostic methods and therapeutic options.
Solmaz Hasdemir P; Guvena T
J BUON; 2016; 21(4):780-786. PubMed ID: 27685896
[TBL] [Abstract][Full Text] [Related]
3. [Clinical recommendations for diagnosing, treatment and monitoring of patients with ovarian cancer -- Croatian Oncology Society and Croatian Society for Gynecology and Obstetrics as Croatian Medical Association units and Croatian Society of Gynecological Oncology].
Matković V; Haller H; Vrdoljak E; Corusić A; Jelavić TB; Strinić T; Karnjus-Begonja R; Barisic D; Tomić S; Kukura V; Ban M; Ranka SP; Matic M; Skalec SL; Topolovec Z; Mrcela M; Zekan J; Fröbe A; Hajredini A; Babic D; Mamula O; Brncić-Fischer A; Vojnović Z; Sundov D; ; ;
Lijec Vjesn; 2013; 135(9-10):235-41. PubMed ID: 24364199
[TBL] [Abstract][Full Text] [Related]
4. Multidisciplinary management of advanced ovarian cancer for an optimal therapeutic strategy.
Heudel PE; Devouassoux-Shisheboran M; Taieb S; Genestie C; Selle F; Morice P; Rouzier R; Ray-Coquard I
Eur J Gynaecol Oncol; 2017; 38(2):175-180. PubMed ID: 29953774
[TBL] [Abstract][Full Text] [Related]
5. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee.
Kurtz JE; Gebski V; Sukhin V; Carey M; Kong I; Glasspool RM; Berek JS; de Paiva Batista M; Hall M; Kim JW; Yeoshoua E; Fujiwara N; Nam BH; Polleis S; Lee JY; Strojna A; Farrelly L; Schwameis R; Fossati R; Darlington AS; Lai CH; Wright AA; Rosenblat O; Harter P; Roxburgh P; Chowdhury RR; Chang TC; Paoletti X; Friedlander M;
Gynecol Oncol; 2021 May; 161(2):502-507. PubMed ID: 33612336
[TBL] [Abstract][Full Text] [Related]
6. BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer.
Grisham RN; Iyer G; Garg K; Delair D; Hyman DM; Zhou Q; Iasonos A; Berger MF; Dao F; Spriggs DR; Levine DA; Aghajanian C; Solit DB
Cancer; 2013 Feb; 119(3):548-554. PubMed ID: 22930283
[TBL] [Abstract][Full Text] [Related]
7. Screening program in ovarian cancer: A logical step in clinical management? A meta-analysis.
Marchetti C; De Felice F; Perniola G; Lecce F; Vertechy L; Monti M; Musio D; Muzii L; Tombolini V; Benedetti Panici P
Curr Probl Cancer; 2018; 42(2):235-240. PubMed ID: 29433824
[TBL] [Abstract][Full Text] [Related]
8. Current status of ovarian cancer surgical management. Argument for centralisation of care in Australia.
Carter J; Pather S; Nascimento M
Aust N Z J Obstet Gynaecol; 2018 Aug; 58(4):474-477. PubMed ID: 29851066
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of outcomes of secondary debulking surgery for recurrent epithelial ovarian cancer with favorable prognostic factors.
Nasu K; Kai K; Hirakawa T; Nishida M; Matsumoto H; Kawano Y; Narahara H
J Obstet Gynaecol Res; 2014 Mar; 40(3):791-6. PubMed ID: 24245582
[TBL] [Abstract][Full Text] [Related]
10. The multidisciplinary approach to ovarian tumours in children and adolescents.
van Heerden J; Tjalma WA
Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():103-110. PubMed ID: 31683108
[TBL] [Abstract][Full Text] [Related]
11. [Initial management of advanced ovarian cancer: What radiological, pathological and surgical information are important for optimal therapeutic strategy?].
Heudel PE; Selle F; Morice P; Rouzier R; Taieb S; Devouassoux-Shisheboran M; Genestie C; Balleyguier C; Ray-Coquard I
Bull Cancer; 2015 Sep; 102(9):772-9. PubMed ID: 26028492
[TBL] [Abstract][Full Text] [Related]
12. [Screening for ovarian cancer].
Bjørge T; Dørum A; Tropé CG
Tidsskr Nor Laegeforen; 2000 May; 120(12):1444-8. PubMed ID: 10851943
[TBL] [Abstract][Full Text] [Related]
13. Malignant mixed müllerian tumors of the ovary.
Navarini R; Pineda RL
Curr Opin Obstet Gynecol; 2006 Feb; 18(1):20-3. PubMed ID: 16493255
[TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer: A review for primary care providers.
Thull T; Kempton D
JAAPA; 2024 Jul; 37(7):32-36. PubMed ID: 38916368
[TBL] [Abstract][Full Text] [Related]
15. Importance of early diagnosis in managing ovarian cancer.
Dunleavey R
Nurs Times; 2006 Oct 10-16; 102(41):28-9. PubMed ID: 17059048
[TBL] [Abstract][Full Text] [Related]
16. Ovarian malignancy.
Niloff JM
Curr Opin Obstet Gynecol; 1991 Feb; 3(1):66-72. PubMed ID: 1878499
[TBL] [Abstract][Full Text] [Related]
17. [Third National Ovarian Consensus. 2011. Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México "GICOM"].
Gallardo-Rincón D; Cantú-de-León D; Alanís-López P; Alvarez-Avitia MA; Bañuelos-Flores J; Herbert-Núñez GS; Oñate-Ocaña LF; Pérez-Montiel MD; Rodríguez-Trejo A; Ruvalcaba-Limón E; Serrano-Olvera A; Ortega-Rojo A; Cortés-Esteban P; Erazo-Valle A; Gerson-Cwilich R; De-la-Garza-Salazar J; Green-Renner D; León-Rodríguez E; Morales-Vásquez F; Poveda-Velasco A; Aguilar-Ponce JL; Alva-López LF; Alvarado-Aguilar S; Alvarado-Cabrero I; Aquino-Mendoza CA; Aranda-Flores CE; Bandera-Delgado A; Barragán-Curiel E; Barrón-Rodríguez P; Brom-Valladares R; Cabrera-Galeana PA; Calderillo-Ruiz G; Camacho-Gutiérrez S; Capdeville-García D; Cárdenas-Sánchez J; Carlón-Zárate E; Carrillo-Garibaldi O; Castorena-Roji G; Cervantes-Sánchez G; Coronel-Martínez JA; Chanona-Vilchis JG; Díaz-Hernández V; Escudero-de-los Ríos P; Garibay-Cerdenares O; Gómez-García E; Herrera-Montalvo LA; Hinojosa-García LM; Isla-Ortiz D; Jiménez-López J; Lavín-Lozano AJ; Limón-Rodriguez JA; López-Basave HN; López-García SC; Maffuz-Aziz A; Martínez-Cedillo J; Martínez-López DM; Medina-Castro JM; Melo-Martínez C; Méndez-Herrera C; Montalvo-Esquivel G; Morales-Palomares MA; Morán-Mendoza A; Morgan-Villela G; Mota-García A; Muñoz-González DE; Ochoa-Carrillo FJ; Pérez-Amador M; Recinos-Money E; Rivera-Rivera S; Robles Flores JU; Rojas-Castillo E; Rojas-Marín C; Salas-Gonzáles E; Sámano-Nateras L; Santibañez-Andrade M; Santillán-Gómez A; Silva-García A; Silva JA; Solorza-Luna G; Tabarez-Ortiz AR; Talamás-Rohana P; Tirado-Gómez LL; Torres-Lobatón A; Quijano-Castro F
Rev Invest Clin; 2011; 63(6):665-702. PubMed ID: 23650680
[TBL] [Abstract][Full Text] [Related]
18. Ovarian dysgerminoma: a therapeutic challenge.
Danhier S; Van Houtte P
J Belge Radiol; 1993 Mar; 76(2):102-4. PubMed ID: 8360136
[TBL] [Abstract][Full Text] [Related]
19. SEOM guideline in ovarian cancer 2014.
Gonzalez-Martín A; Bover I; Del Campo JM; Redondo A; Vidal L;
Clin Transl Oncol; 2014 Dec; 16(12):1067-71. PubMed ID: 25351169
[TBL] [Abstract][Full Text] [Related]
20. Borderline ovarian tumours: a review of the recent literature.
Crispens MA
Curr Opin Obstet Gynecol; 2003 Feb; 15(1):39-43. PubMed ID: 12544500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
